DHGF(SH:600257)2023-10-30 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥282,731,220.16, a decrease of 1.99% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥13,501,914.25, down 20.19% year-on-year[5]. - The basic earnings per share for Q3 2023 was ¥0.0281, reflecting a decline of 20.29% compared to the previous year[6]. - Total revenue for the first three quarters of 2023 reached ¥872,830,730.71, an increase of 5.5% compared to ¥828,096,797.74 in the same period of 2022[23]. - Net profit for the first three quarters of 2023 was ¥20,108,652.59, compared to ¥6,695,268.38 in the same period of 2022, indicating a significant increase of 200.4%[24]. - The company reported a total comprehensive income of ¥24,142,231.35 for the first three quarters of 2023, compared to ¥6,695,268.38 in 2022, reflecting a substantial increase[25]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,130,420,889.75, a decrease of 1.46% from the end of the previous year[6]. - The company's total liabilities decreased to ¥1,105,248,241.07 from ¥1,160,504,202.31, a reduction of approximately 4.8%[20]. - The total equity attributable to shareholders increased to ¥886,103,842.34 from ¥879,723,654.23, showing a growth of 0.4%[20]. - The company's total liabilities as of September 30, 2023, included short-term borrowings of RMB 298,818,489.44, an increase from RMB 263,806,070.52 at the end of 2022[18]. - The company's non-current assets totaled RMB 1,146,973,590.55, down from RMB 1,208,517,210.36 at the end of 2022, reflecting a decrease of approximately 5.09%[18]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥42,837,061.53, an increase of 154.00% compared to the same period last year[10]. - The net cash flow from operating activities for the first three quarters of 2023 was ¥42,837,061.53, significantly up from ¥16,864,970.89 in the first three quarters of 2022[28]. - The total cash inflow from investment activities in the first three quarters of 2023 was ¥27,306,994.00, a decrease of 74.9% from ¥108,669,938.52 in the same period of 2022[29]. - The net cash flow from financing activities for the first three quarters of 2023 was ¥10,525,553.59, recovering from a negative cash flow of -¥43,220,571.46 in the same period of 2022[29]. - The company experienced a net increase in cash and cash equivalents of ¥57,112,995.99 in Q3 2023, contrasting with a net decrease of -¥74,389,449.15 in Q3 2022[29]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 71,516[12]. - The company’s major shareholder, Tibet Hongshan Technology Development Co., Ltd., holds 104,631,211 shares, representing 21.74% of total shares[14]. - The company reported a total of 13,953,762 shares held by shareholder Fan Yuanlong, accounting for 2.90% of total shares[14]. Operational Changes - The company reported a significant increase in prepayments by 46.38%, attributed to increased sales of frozen products[10]. - The company experienced a 58.40% rise in other receivables due to the transfer of equity in a subsidiary[10]. - The company’s subsidiary, Hunan Xiangyun Biotechnology Co., Ltd., filed for bankruptcy reorganization on July 5, 2023, resulting in the loss of financial and operational control over it[15]. Research and Development - Research and development expenses for the first three quarters of 2023 were ¥840,711.32, up from ¥754,558.28 in 2022, marking an increase of 11.4%[23].